Vectus Biosystems Ltd - ESG Rating & Company Profile powered by AI
Scroll down to the end of the webpage for potential risks for Vectus Biosystems Ltd based on industry, location and marketcap. If you work at Vectus Biosystems Ltd and you wish to use your Sustainability aseessment, please contact us. The report of Vectus Biosystems Ltd incorporates intelligence from across the web as well as from available documents by Vectus Biosystems Ltd.
Vectus Biosystems Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.8; made up of an environmental score of 4.0, social score of 8.0 and governance score of 5.3.
5.8
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 521 | Smruthi Organics Ltd | 5.9 | High |
| 521 | Vectura Group PLC | 5.9 | High |
| 541 | Vectus Biosystems Ltd | 5.8 | High |
| 541 | Cantargia AB | 5.8 | High |
| 541 | Amplia Therapeutics Ltd | 5.8 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Vectus Biosystems Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Vectus Biosystems Ltd report the average age of the workforce?
Sign up for free to unlockDoes Vectus Biosystems Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Vectus Biosystems Ltd offer flexible work?
Sign up for free to unlockDoes Vectus Biosystems Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Vectus Biosystems Ltd conduct supply chain audits?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Vectus Biosystems Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose water use targets?
Sign up for free to unlockDoes Vectus Biosystems Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Vectus Biosystems Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Vectus Biosystems Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Vectus Biosystems Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Vectus Biosystems Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Vectus Biosystems Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Vectus Biosystems Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose its waste policy?
Sign up for free to unlockDoes Vectus Biosystems Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose energy use targets?
Sign up for free to unlockDoes Vectus Biosystems Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Vectus Biosystems Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Vectus Biosystems Ltd
These potential risks are based on the size, segment and geographies of the company.
Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure, which include treatments for heart, kidney, liver, and lung diseases. Its lead compound is VB0004, which is aimed at treating the loss of functional tissue to fibrosis, scarring, and high blood pressure. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops AccuCal and RealCount software that enhance speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. The company was incorporated in 2005 and is based in Rosebery, Australia.